by Usha Govindarajulu | May 26, 2021 | Biostatistics, Blog, Usha Govindarajulu
COVID-19 challenges of publishing statistically relevant studies COVID-19 is a tricky period in which to attempt to publish new studies. Criticism came from reviewers and those reading the articles whether or not one showed negative results or positive results from...
by Usha Govindarajulu | Mar 17, 2021 | Usha Govindarajulu
Doing research in COVID-19 presents many types of problems for having statistical analyses free from biases. In studies that were organized as observational studies to compare treatments or differences on some outcome between COVID-19 patients and either some type of...
by Usha Govindarajulu | Mar 3, 2021 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
As of right now, this is what we know about serious safety concerns raised about these COVID-19 vaccines: the mRNA vaccines, Pfizer© and Moderna©, the Johnson & Johnson©vaccine, and the Oxford/Astrazeneca© vaccine. These are the current vaccines with...
by Usha Govindarajulu | Feb 17, 2021 | Blog, Epidemiology, Healtcare, New York, Professor, Usha Govindarajulu
Much of the new these days focuses around the vaccines that are out on the market due to emergency authorizations for their use due the continued spread and decimation caused by COVID-19. One of the major concerns that have been raised besides safety are also how the...
by Usha Govindarajulu | Feb 3, 2021 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
Recently, two more vaccines are being reviewed in the news for their efficacy and usefulness in the fight against COVID-19. The producers are Johnson & Johnson and Novavax. The Johnson & Johnson or J&J has been discussed earlier than the other since it...
by Usha Govindarajulu | Jan 20, 2021 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
As we continue to hear news of COVID-19 variants making their landfall and presence in the United States, the mass vaccination campaign continues. Meanwhile as cases continue to surge, hospitals are overflowing, and deaths have reached almost 400,000, vaccinations...
